1 Mikashakar

Nrsa Doctoral Dissertation And Other Research Experience

Part 1. Overview Information

It is critical that applicants follow the Fellowship (F) instructions in the SF424 (R&R) Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

  • Use the NIH ASSIST system to prepare, submit and track your application online.
  • Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.

  • Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.
  • Table of Contents

    Part 1. Overview Information
    Part 2. Full Text of the Announcement
    Section I. Funding Opportunity Description
    Section II. Award Information
    Section III. Eligibility Information
    Section IV. Application and Submission Information
    Section V. Application Review Information
    Section VI. Award Administration Information
    Section VII. Agency Contacts
    Section VIII. Other Information

    Part 2. Full Text of Announcement

    Section I. Funding Opportunity Description

    The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NRSA fellowships support the training of pre- and postdoctoral scientists, dual-degree investigators, and senior researchers.  More information about NRSA programs may be found at the Ruth L. Kirschstein National Research Service Award (NRSA) website.

    The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research. Applicants for this F31 program are expected to propose a dissertation research project and training plan in scientific health-related fields relevant to the mission of the participating Institutes and Centers. This training plan should reflect the applicant’s dissertation research project, and facilitate and clearly enhance the individual’s potential to develop into a productive, independent research scientist. The training plan should document the need for, and the anticipated value of, the proposed mentored research and training in relationship to the individual’s research career goals. The training plan should also facilitate the fellow’s transition to the next stage of his/her research career.

    It is expected that the mentored research training experience will provide:

    • A strong foundation in research design, methods, and analytic techniques appropriate to the proposed dissertation research;
    • The enhancement of the applicant's ability to conceptualize and think through research problems with increasing independence;
    • Experience conducting research using appropriate, state-of-the-art methods, as well as presenting and publishing the research findings as first author;
    • The opportunity to interact with members of the scientific community at appropriate scientific meetings and workshops;
    • Skills needed to transition to the next stage of the applicant’s research career; and
    • The opportunity to enhance the applicant’s understanding of the health-related sciences and the relationship of the proposed research to health and disease.

    Applicants for the F31 must be candidates for the PhD degree and have identified a dissertation research project and sponsor(s).

    The Kirschstein-NRSA Individual Predoctoral Fellowship (F31) program may provide up to five years (typically 2-3 years) of support for research training which leads to the PhD or equivalent research degree, the combined MD/PhD degree, or another formally combined professional degree and research doctoral degree in the biomedical, behavioral, or clinical sciences. Because this F31 program only supports dissertation research training, the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30) program will be more appropriate for the training goals of individuals enrolled in dual-degree programs who seek support for both dissertation research training and clinical training.

    Special Note: Because of the differences in individual Institute and Center (IC) program requirements for this FOA, prospective applicants are strongly encouraged to consult the Table of IC-Specific Information, Requirements and Staff Contacts, to make sure that their application is responsive to the requirements of one of the participating NIH ICs.

    See Section VIII. Other Information for award authorities and regulations.

    Section II. Award Information

    Funding Instrument

    Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

    Application Types Allowed

    New
    Resubmission
    Renewal: Individual fellowship awards are generally not renewable. In rare cases in which fellowship awardees require further fellowship support, they should consult with NIH staff to obtain advice regarding submission of a renewal application.
    The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

    Funds Available and Anticipated Number of Awards

    The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

    Award Budget

    Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below.

    Award Project Period

    Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the predoctoral level including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. This F31 award program only supports dissertation research training.

    Other Award Budget Information

    Institutional Allowance

    The application should request a Kirschstein-NRSA institutional allowance to help defray the cost of fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. See https://researchtraining.nih.gov/resources/policy-notices

    Stipend levels, as well as funding amounts for tuition and fees and the institutional allowance are announced annually in the NIH Guide for Grants and Contracts, and are also posted on the Ruth L. Kirschstein National Research Service Award (NRSA) webpage.

    NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.

    Section III. Eligibility Information

    1. Eligible Applicants

    Eligible Organizations

    Higher Education Institutions

    • Public/State Controlled Institutions of Higher Education
    • Private Institutions of Higher Education

    The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

    •     Hispanic-serving Institutions
    •     Historically Black Colleges and Universities (HBCUs)
    •     Tribally Controlled Colleges and Universities (TCCUs)
    •     Alaska Native and Native Hawaiian Serving Institutions
    •     Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

    Nonprofits Other Than Institutions of Higher Education

    • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
    • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

    For-Profit Organizations

    • Small Businesses
    • For-Profit Organizations (Other than Small Businesses)

    Governments

    • Eligible Agencies of the Federal Government

    Other

    • Non-domestic (non-U.S.) Entities (Foreign Institutions)

    Before submitting a fellowship application, the applicant must identify a sponsoring institution. The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training. The research training should occur in a strong research environment that has appropriate human and technical resources and is demonstrably committed to training in the field(s) proposed by the applicant. The sponsoring institution may be private (profit or nonprofit) or public, including the NIH Intramural Programs and other Federal laboratories. All institutions with the appropriate resources and commitment are encouraged to apply.

    Foreign Institutions

    Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
    Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
    Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

    An individual may request support for research training abroad. In such cases, the applicant is required to provide detailed justification for the foreign training, including the reasons why the facilities, the sponsor, or other aspects of the proposed training are more appropriate than training in a domestic setting. The justification will be evaluated in terms of the scientific advantages of the foreign training as compared to the training available domestically. Foreign training will be considered for funding only when the scientific advantages are clear.

    Required Registrations

    Applicant Organizations

    Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

    Program Directors/Principal Investigators (PD(s)/PI(s))

    All PD(s)/PI(s) [for fellowships, this is the applicant] must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons.If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

    Eligible Individuals (Program Director/Principal Investigator)

    Any applicant fellow with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with his/her sponsor and organization to develop an application

    • Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
    • System for Award Management (SAM) (formerly CCR) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
    • NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. 
    • eRA Commons - Applicants must have an active DUNS number and SAM registration in order to complete the eRA Commons registration. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
    • Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration.

    for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Multiple PDs/PIs are not allowed.

    By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).  

    The applicant must be at the dissertation research stage of training at the time of award and must show evidence of high academic performance in the sciences, and commitment to a career as an independent research scientist.

    The applicant must be currently enrolled in a PhD or equivalent research degree program (e.g., EngD, DNSc, DrPH, DSW, PharmD, ScD) in the biomedical, behavioral, or clinical sciences at a domestic or foreign institution.

    Students matriculated in a dual-degree program (e.g. MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) who seek support for both dissertation research training and clinical training are not eligible for this Kirschstein-NRSA F31 program because this F31 program does not support the clinical training component of a dual-degree program. Such students may apply for the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30) to support both dissertation research training and clinical training.

    2. Cost Sharing

    This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

    3. Additional Information on Eligibility

    Number of Applications

    The NIH will not accept duplicate or highly overlapping applications under review at the same time.  This means that the NIH will not accept:

    • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
    • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
    • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

    Duration of Support

    Individuals may not exceed the aggregate limit of NRSA support shown above in the Award Project Period (see Section II. Award Information). Applicant fellows must consider any prior NRSA research training in determining the duration of support requested. Information regarding previous Kirschstein-NRSA support must be included in the application and will be considered at the time of award.

    Level of Effort

    At the time of award, individuals are required to pursue their research training on a full-time basis, normally defined as 40 hours per week or as specified by the sponsoring institution in accordance with its own policies.

    Sponsor

    Before submitting the application, the applicant must identify a sponsor(s) who will supervise the proposed mentored training experience. The primary sponsor should be an active investigator in the area of the proposed research training and be committed both to the applicant’s research training and to direct supervision of his/her research. The sponsor must document the availability of sufficient research funds and facilities for high-quality research training. The sponsor, or a member of the sponsor team, should have a successful track record of mentorship. Applicants are encouraged to identify more than one sponsor, i.e., a sponsor team, if this is deemed advantageous for providing expert advice in all aspects of the training program. When there is a sponsor team, one individual must be identified as the primary sponsor, and will be expected to coordinate the applicant’s overall training. The applicant must work with the sponsor(s) in preparing the application.

    Section IV. Application and Submission Information

    1. Requesting an Application Package

    Applicants must obtain the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.

    2. Content and Form of Application Submission

    It is critical that applicants follow the Fellowship (F) instructions in the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

    Page Limitations

    All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.

    Instructions for Application Submission

    The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.

    SF424(R&R) Cover

    All instructions in the SF424 (R&R) Application Guide must be followed.  

    SF424(R&R) Project/Performance Site Locations

    All instructions in the SF424 (R&R) Application Guide must be followed.  

    Other Project Information

    All instructions in the SF424 (R&R) Application Guide must be followed.

    SF424(R&R) Senior/Key Person Profile Expanded

    All instructions in the SF424 (R&R) Application Guide must be followed.  

    PHS Fellowship Supplemental Form

    The PHS Fellowship Supplemental Form is comprised of the following sections:

    • Fellowship Applicant
    • Research Training Plan
    • Sponsor(s), Collaborator(s), and Consultant(s);
    • Institutional Environment & Commitment to Training
    • Other Research Training Plan Sections
    • Additional Information
    • Budget
    • Appendix

    All instructions in the SF424 (R&R) Application Guide must be followed.

    PHS Inclusion Enrollment Report

    When conducting clinical research, follow all instructions for completing PHS Inclusion Enrollment Report as described in the SF424 (R&R) Application Guide.

    PHS Assignment Request Form

    All instructions in the SF424 (R&R) Application Guide must be followed. 

    Letters of Reference

    Applicants must carefully follow the SF424 (R&R) Application Guide, including the time period for when letters of reference will be accepted.

    It is important to note that neither the sponsor nor any co-sponsor of this application may serve as a reference for the application. The sponsor/cosponsor's recommendation is included as part of the application.

    Applications lacking the appropriate required reference letters will not be reviewed. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Submit Reference Letter link and not through Grants.gov.

    Foreign Institutions

    Foreign (non-U.S.) Institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.

    3. Unique Entity Identifier and System for Award Management (SAM)

    See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov.

    4. Submission Dates and Times

    Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

    Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Add Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.

    Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

    Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

    5. Intergovernmental Review (E.O. 12372)

    This initiative is not subject to intergovernmental review.

    6. Funding Restrictions

    All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The National Research Service Award (NRSA) policies apply to this program.  A Kirschstein-NRSA fellowship may not be held concurrently with another federally sponsored fellowship or similar Federal award that provides a stipend or otherwise duplicates provisions of this award.

    Pre-award costs are generally not allowable for Fellowships.

    7. Other Submission Requirements and Information

    Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide.  Paper applications will not be accepted.

    Applicants must complete all required registrations before the application due date.Section III. Eligibility Information contains information about registration.

    For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Guidelines for Applicants Experiencing System Issues. For assistance with application submission, contact the Application Submission Contacts in Section VII.

    Important reminders:
    All PD(s)/PI(s) and sponsor(s) must include their eRA Commons ID in the Credential fieldof the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.

    The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management (SAM). Additional information may be found in the SF424 (R&R) Application Guide.

    See more tips for avoiding common errors.

    Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.

    Post Submission Materials

    Applicants are required to follow our Post Submission Application Materials policy. Because the sponsor(s)’ research funding is an important factor in the review of a fellowship application, post-submission material that updates the sponsor(s)’ funding information in the originally submitted application is allowed. Information on the sponsor(s)’ research funding must not exceed 1 page, and is limited to the project title, funding source (e,g. NIH grant number), and a brief description of the Specific Aims and relevance to the fellowship application under review. The additional material is due no later than 30 days prior to the meeting of the review committee.

    Section V. Application Review Information

    1. Criteria

    Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.

    For this particular announcement, note the following:

    • A fellowship application has a research project that is integrated with the training plan. The review will emphasize the applicant’s potential for an independent, scientific research career, the applicant’s need for the proposed training, and the degree to which the research project and training plan, the sponsor(s), and the environment will satisfy those needs.

    Overall Impact/Merit

    Reviewers will provide an overall impact score to reflect their assessment of the likelihood that the fellowship will enhance the applicant’s potential for, and commitment to, a productive independent scientific research career in a health-related field, in consideration of the scored and additional review criteria.

    Scored Review Criteria

    Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact.

    Fellowship Applicant

    • Are the applicant’s academic record and research experience of high quality?
    •  oes the applicant have the potential to develop into an independent and productive researcher?
    • Does the applicant demonstrate commitment to a research career in the future?

    Sponsors, Collaborators, and Consultants

    •   Are the sponsor(s’) research qualifications (including recent publications) and track record of mentoring individuals at a similar stage appropriate for the needs of the applicant?
    •   Is there evidence of a match between the research and clinical interests (if applicable) of the applicant and the sponsor(s)? Do(es) the sponsor(s) demonstrate an understanding of the applicant’s training needs as well as the ability and commitment to assist in meeting these needs?
    • Is there evidence of adequate research funds to support the applicant’s proposed research project and training for the duration of the research component of the fellowship?
    •   If a team of sponsors is proposed, is the team structure well justified for the mentored training plan, and are the roles of the individual members appropriate and clearly defined?
    •  Are the qualifications of any collaborator(s) and/or consultant(s), including their complementary expertise and previous experience in fostering the training of fellows, appropriate for the proposed project?

    Research Training Plan

    •  Is the proposed research project of high scientific quality, and is it well integrated with the proposed research training plan?
    •   Based on the sponsor’s description of his/her active research program, is the applicant’s proposed research project sufficiently distinct from the sponsor’s funded research for the applicant’s career stage?
    •  Is the research project consistent with the applicant’s stage of research development?
    •   Is the proposed time frame feasible to accomplish the proposed training?

    Training Potential

    •   Are the proposed research project and training plan likely to provide the applicant with the requisite individualized and mentored experiences in order to obtain appropriate skills for a research career?
    •  D oes the training plan take advantage of the applicant’s strengths and address gaps in needed skills?  Does the training plan document a clear need for, and value of, the proposed training?
    •  Does the proposed training have the potential to serve as a sound foundation that will clearly enhance the applicant’s ability to develop into a productive researcher?

    Institutional Environment & Commitment to Training

    • Are the research facilities, resources (e.g., equipment, laboratory space, computer time, subject populations), and training opportunities (e.g. seminars, workshops, professional development opportunities) adequate and appropriate?
    •  Is the institutional environment for the applicant’s scientific development of high quality?
    •  Is there appropriate institutional commitment to fostering the applicant’s mentored training.

    Additional Review Criteria

    As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

    Protections for Human Subjects

    For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

    For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

    Inclusion of Women, Minorities, and Children 

    When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of children to determine if it is  justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.

    Vertebrate Animals

    The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.

    Biohazards

    Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.

    Resubmissions

    For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

    Renewals

    For Renewals, the committee will consider the progress made in the last funding period.

    Revisions

    Not Allowed

    Additional Review Considerations

    As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

    Training in the Responsible Conduct of Research

    All applications for support under this FOA must include a plan to fulfill NIH requirements for Instruction in the Responsible Conduct of Research (RCR).  Taking into account the level of experience of the applicant, including any prior instruction or participation in RCR as appropriate for the applicant’s career stage, the reviewers will evaluate the adequacy of the proposed RCR training in relation to the following five required components: 1) Format - the required format of instruction, i.e., face-to-face lectures, coursework, and/or real-time discussion groups (a plan with only on-line instruction is not acceptable); 2) Subject Matter - the breadth of subject matter, e.g., conflict of interest, authorship, data management, human subjects and animal use, laboratory safety, research misconduct, research ethics; 3) Faculty Participation - the role of the sponsor(s) and other faculty involvement in the fellow’s instruction; 4) Duration of Instruction - the number of contact hours of instruction (at least eight contact hours are required); and 5) Frequency of Instruction – instruction must occur during each career stage and at least once every four years.  Plans and past record will be rated as ACCEPTABLE or UNACCEPTABLE, and the summary statement will provide the consensus of the review committee. See also: NOT-OD-10-019.

    Applications from Foreign Organizations

    Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.

    Select Agent Research

    Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

    Resource Sharing Plans

    Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genomic Data Sharing Plan.

    Budget and Period of Support

    Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

    2. Review and Selection Process

    Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.


    As part of the scientific peer review, all applications:

    • May undergo a committee process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.
    • Will receive a written critique.

    Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications. Following initial peer review, recommended applications will receive a second level of review by the appropriate NIH Institute or Center.  The following will be considered in making funding decisions:

    • Scientific and technical merit of the proposed project as determined by scientific peer review.
    • Availability of funds.
    • Relevance of the proposed project to program priorities.

    3. Anticipated Announcement and Award Dates

    After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

    Information regarding the disposition of applications is available in the NIH Grants Policy Statement.

    Section VI. Award Administration Information

    1. Award Notices

    If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

    A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee’s business official.

    Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.      

    Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website.  This includes any recent legislation and policy applicable to awards that is highlighted on this website.

    2. Administrative and National Policy Requirements

    All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General  and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.

    Recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights law. This means that recipients of HHS funds must ensure equal access to their programs without regard to a person’s race, color, national origin, disability, age and, in some circumstances, sex and religion. This includes ensuring your programs are accessible to persons with limited English proficiency.  HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research.

    For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA. HHS provides general guidance to recipients of FFA on meeting their legal obligation to take reasonable steps to provide meaningful access to their programs by persons with limited English proficiency. Please see http://www.hhs.gov/ocr/civilrights/resources/laws/revisedlep.html. The HHS Office for Civil Rights also provides guidance on complying with civil rights laws enforced by HHS. Please see http://www.hhs.gov/ocr/civilrights/understanding/section1557/index.html; and http://www.hhs.gov/ocr/civilrights/understanding/index.html. Recipients of FFA also have specific legal obligations for serving qualified individuals with disabilities. Please see http://www.hhs.gov/ocr/civilrights/understanding/disability/index.html. Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at http://www.hhs.gov/ocr/office/about/rgn-hqaddresses.html or call 1-800-368-1019 or TDD 1-800-537-7697. Also note it is an HHS Departmental goal to ensure access to quality, culturally competent care, including long-term services and supports, for vulnerable populations. For further guidance on providing culturally and linguistically appropriate services, recipients should review the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care at http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53.

    Inventions and Copyrights

    Fellowships funded primarily for educational purposes are exempted from the PHS invention requirements and thus invention reporting is not required. More details, including exceptions for fellows training at NIH are provided in the NIH Grants Policy Statement.

    3. Reporting

    When multiple years are involved, awardees will be required to submit the Research Performance Progress Report (RPPR) annually. The report is due two months before the beginning date of the next budget period and must include information describing the current year's progress as well as the research and training plans for the coming year.

    The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later.  All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000.  See the NIH Grants Policy Statement for additional information on this reporting requirement. 

    Other Fellowship Reporting Requirements:

    • Individuals admitted to the United States as Permanent Residents must submit notarized evidence of legal admission prior to the award.
    • The fellowship award recipient has up to six months from the issue date on the Notice of Award to activate the award using the Kirschstein-NRSA Individual Fellowship Activation Notice (PHS 416-5). Under unusual circumstances, NIH may grant an extension of the activation period upon receipt of a specific request from the fellow. Such a request must be countersigned by the sponsor and an authorized institutional official.
    • At the conclusion of a fellowship, the fellow must submit a Termination Notice (PHS 416-7) via xTrain to the NIH within 30 days of termination. Fellows with service payback requirements must notify the NIH of any change in address and submit Annual Payback Activities Certification Forms (PHS 6031-1) until the payback service obligation is satisfied.

    4. Evaluation

    In carrying out its stewardship of human resource-related programs, the NIH may request information essential to an assessment of the effectiveness of this program from databases and from participants themselves.  Participants may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.

    Section VII. Agency Contacts

    We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

    Because of the difference in individual Institute and Center (IC) program requirements for this FOA, prospective applications MUST consult the Table of IC-Specific Information, Requirements and Staff Contacts, to make sure that their application is responsive to the requirements of one of the participating NIH ICs. Prior consultation with NIH staff is strongly encouraged.

    Application Submission Contacts

    eRA Service Desk (Questions regarding ASSIST, eRA Commons registration, submitting and tracking an application, documenting system problems that threaten submission by the due date, post submission issues)
    Finding Help Online: https://grants.nih.gov/support/ (preferred method of contact)
    Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

    Grants.gov Customer Support(Questions regarding Grants.gov registration and submission, downloading forms and application packages)
    Contact Center Telephone: 800-518-4726
    Email: support@grants.gov

    GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
    Email: GrantsInfo@nih.gov (preferred method of contact)
    Telephone: 301-945-7573

    Scientific/Research Contact(s)

    Table of IC-Specific Information, Requirements and Staff Contacts

    Peer Review Contact(s)

    Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

    Financial/Grants Management Contact(s)

    Table of IC-Specific Information, Requirements and Staff ContactsReplace this text with Staff

    Section VIII. Other Information

    Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

    Authority and Regulations

    Awards are made under the authorization of Section 487 of the Public Health Service Act as amended (42 USC 288) and under Federal Regulations 42 CFR 66.

    G.430 - PHS Fellowship Supplemental Form

    The PHS Fellowship Supplemental Form is used only for fellowship applications.

    This form includes fields to upload several attachments including the Specific Aims, Research Strategy, and Applicant Background and Goals.

    The attachments in this form should include sufficient information needed for evaluation of the project and fellow, independent of any other document (e.g., previous application). Be specific and informative, and avoid redundancies.

    Who should use the PHS Fellowship Supplemental Form:

    Use the PHS Fellowship Supplemental Form only if you are submitting a fellowship application.

    Fellowship applicants and sponsors are strongly encouraged to speak with a PHS Program Official for Institute- or Center (IC)-specific guidance before preparing this application. Refer to the Table of IC-specific Information, Requirements, and Staff Contacts in your FOA. In addition, a list of contacts specifically for extramural training at the NIH ICs can be found at NIH Training Advisory Committee Roster. For AHRQ, see Research Training Staff Contacts. You are encouraged to check these websites at any time for the most current contact information.

    It is important that the attachments in this form be developed in collaboration with your sponsor, but they should be written by you, the fellowship applicant.

    Read all the instructions in the FOA before completing this section to ensure that your application meets all IC-specific criteria.

    Applicants must follow all policies and requirements related to proprietary information, page limits, and formatting. See the following pages for more information:

    Introduction

    1. Introduction (RESUBMISSION)

    Who must complete the "Introduction" attachment:

    An "Introduction" attachment is required only if the type of application is resubmission or if the FOA specifies that one is needed. An introduction is not allowed for new or renewal applications.

    Descriptions of different types of applications are listed here: NIH Types of Applications.

    Format:

    Follow the page limits for the Introduction in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Resubmission applications: See specific instructions on the content of the Introduction on the NIH's Resubmission Applications page.

    Fellowship Applicant Section

    2. Applicant's Background and Goals for Fellowship Training

    Who must complete the "Applicant's Background and Goals for Fellowship Training" attachment:

    The "Applicant's Background and Goals for Fellowship Training" attachment is required.

    Format:

    Follow the page limits for Applicant's Background and Goals for Fellowship Training in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Organize the Applicant's Background and Goals for Fellowship Training attachment in the specified order and use the instructions provided below unless otherwise specified in the FOA. Start each section with the appropriate heading - Doctoral Dissertation and Research Experience, Training Goals and Objectives, Activities Planned Under this Award.

    A. Doctoral Dissertation and Research Experience:

    Briefly summarize your past research experience, results, and conclusions, and describe how that experience relates to the proposed fellowship. In some cases, a proposed fellowship may build directly on previous research experiences, results, and conclusions. In other situations, past research experiences may lead a candidate to apply for a fellowship in a new or different area of research. Do not list academic courses in this section.

    Applicants with no research experience: Describe any other scientific experiences.

    Advanced graduate students (i.e., those who have or will have completed their comprehensive examinations by the time of award): Include a narrative of your planned doctoral dissertation (may be preliminary).

    Postdoctoral fellowship applicants: Specify which areas of research were part of your predoctoral thesis or dissertation and which, if any, were part of a previous postdoctoral project.

    B. Training Goals and Objectives:
    • Describe your overall training goals for the duration of the fellowship and how the proposed fellowship will enable the attainment of these goals.
    • Identify the skills, theories, conceptual approaches, etc. to be learned or enhanced during the award.
    • Discuss how the proposed research will facilitate your transition to the next career stage, if applicable.
    C. Activities Planned Under this Award:

    The activities planned under this award should be individually tailored and well integrated with your research project.

    • Describe, by year, the activities (research, coursework, professional development, clinical activities, etc.) you will be involved in during the proposed award. Estimate the percentage of time to be devoted to each activity. The percentage should total 100 for each year.
    • Describe the research skills and techniques that you intend to learn during the award period.
    • Describe the planned, non-research activities (e.g. those related to professional development and clinical activities) that you plan to engage in during the award period.
    • Provide a timeline detailing the proposed research training and related activities for the entire duration of the fellowship award.

    Research Training Plan Section

    A Research Training Plan is required for all types of fellowship awards and is a major part of the fellowship application. It is important to relate the proposed research to the applicant's scientific career goals. Explain the relationship between the applicant's research on the fellowship award and the mentor's ongoing research program.

    The information in these introductory paragraphs to the Research Training Plan Section applies to all Research Training Plan Section attachments: Specific Aims, Research Strategy, Respective Contributions, Selection of Sponsor and Institution, Progress Report Publication List, and Training in the Responsible Conduct of Research.

    For most types of research, the plan should include:

    • a specific hypothesis,
    • a list of the specific aims and objectives that will be used to examine the hypothesis,
    • a description of the methods/approaches/techniques to be used in each aim,
    • a discussion of possible problems and how they will be managed, and
    • alternative approaches that might be tried if the initial approaches do not work.

    The Research Training Plan is expected to be tailored to the experience level of the applicant and to allow him/her to develop the necessary skills for further career advancement. Reviewers will evaluate the plan accordingly. The plan should be achievable within the requested time period. Pilot or preliminary studies and routine data gathering are generally not appropriate as the focus of the Research Training Plan.

    Although applicants for fellowship awards are expected to write the Research Training Plan, the mentor should review a draft of the plan and discuss it in detail with the applicant. Review by other knowledgeable colleagues is also helpful. Although it is understood that fellowship applications do not require the extensive experimental detail usually incorporated into regular research grant applications, a fundamentally sound Research Training Plan should be provided.

    3. Specific Aims

    Who must complete the "Specific Aims" attachment:

    The "Specific Aims" attachment is required unless otherwise specified in the FOA.

    Format:

    Follow the page limits for Specific Aims in the NIH Table of Page Limits, unless otherwise specified in the FOA.

    Attach this information as a PDF. See NIH's Format Attachments page.

    Content:

    State concisely the goals of the proposed research and summarize the expected outcome(s), including the impact that the results of the proposed research will have on the research field(s) involved.

    List succinctly the specific objectives of the research proposed (e.g., to test a stated hypothesis, create a novel design, solve a specific problem, challenge an existing paradigm or clinical practice, address a critical barrier to progress in the field, or develop new technology).

    4. Research Strategy

    Who must complete the "Research Strategy" attachment:

    The "Research Strategy" attachment is required.

    Format:

    Follow the page limits for the Research Strategy in the NIH Table of Page Limits unless otherwise specified in the FOA. Although multiple sections of information are required in the Research Strategy as detailed below, the page limit applies to the entirety of the single Research Strategy attachment.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Organize the Research Strategy in the specified order and use the instructions provided below, unless otherwise specified in the FOA. Start each section with the appropriate section heading - Significance, Innovation, Approach. Cite published experimental details in the Research Strategy and provide the full reference in G.220 - R&R Other Project Information Form, Bibliography and References Cited.

    1. Significance
    • Explain the importance of the problem or critical barrier to progress that the proposed project addresses.
    • Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields.
    • Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.
    2. Innovation
    • Fellowship applicants should not include an Innovation section except in the unusual circumstance where it is specified in the FOA.
    3. Approach
    • Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Unless addressed separately in the Resource Sharing Plan attachment, include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate.
    • Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims.
    • If the project is in the early stages of development, describe any strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.
    • Point out any procedures, situations, or materials that may be hazardous to personnel and the precautions to be exercised. A full discussion on the use of select agents should appear in the Select Agent Research attachment below.
    • If research on Human Embryonic Stem Cells (hESCs) is proposed, but an approved cell line from the NIH hESC Registry cannot be chosen, provide a strong justification for why an appropriate cell line cannot be chosen from the registry at this time.

    If you have multiple Specific Aims, you may address Significance, Innovation, and Approach either for each Specific Aim individually or for all of the Specific Aims collectively.

    As applicable, also include the following information as part of the Research Strategy, keeping within the three sections (Significance, Innovation, and Approach) listed above.

    Preliminary Studies for New Applications:

    For new applications, include information on preliminary studies (including data collected by others in the lab), if any. Discuss the applicant's preliminary studies, data, and/or experience pertinent to this application.

    Progress Report for Renewal Applications:

    Note that the Progress Report falls within the Research Strategy and is therefore included in the page limits for the Research Strategy.

    Renewal applications for individual fellowships are rare. You should consult with your program official before preparing such an application. If you are submitting a renewal application, provide a Progress Report. Provide the beginning and ending dates for the period covered since the last competitive review. In the Progress Report, you should:

    • Summarize the specific aims of the previous project period and the importance of the findings, and emphasize the progress made toward their achievement.
    • Explain any significant changes to the specific aims and any new directions, including changes resulting from significant budget reductions.
    • Discuss previous participant enrollment (e.g., recruitment, retention, inclusion of women, minorities, children, etc.) for any studies meeting the NIH Glossary definition for clinical research, particularly if relevant to studies proposed in the renewal application. You should not submit a PHS Inclusion Enrollment Report unless the enrollment is part of new or ongoing studies in the renewal application.

    Do not include a list of publications, manuscripts accepted for publication, patents, or other printed materials in the Progress Report. That information will be included in the "Progress Report Publication List" attachment.

    5. Respective Contributions

    Who must complete the "Respective Contributions" attachment:

    The "Respective Contributions" attachment is required.

    Format:

    Follow the page limits for Respective Contributions in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Describe the collaborative process between you and your sponsor/co-sponsor(s) in the development, review, and editing of this Research Training Plan. Also discuss your respective roles in accomplishing the proposed research.

    6. Selection of Sponsor and Institution

    Who must complete the "Selection of Sponsor and Institution" attachment:

    The "Selection of Sponsor and Institution" attachment is required.

    Format:

    Follow the page limits for Selection of Sponsor and Institution in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Describe the rationale/justification for the selection of both the sponsor and the institution.

    1. Explain why the sponsor, co-sponsor (if any), and institution were selected to accomplish the research training goals. If the proposed research training is to take place at a site other than the applicant organization, provide an explanation here.
    2. Foreign Institution. If you are proposing a research training experience at a foreign institution, describe how that the foreign institution and sponsor offer special opportunities for training that are not currently available in the United States. Key factors in the selection of a foreign institution should be described. The need for and level of proficiency in reading, speaking, and comprehending the foreign language should be addressed.
    3. Postdoctoral and Senior Fellowship Applicants requesting training at their Doctorate or Current Institution: Training is expected to broaden a fellow's perspective. Therefore, if you are requesting training at either your doctorate institution or any institution where you have been training for more than a year, you must explain why further training at that institution would be valuable. Individuals applying for senior fellowships who are requesting training at the institution at which they are employed should provide a similar explanation.

    7. Progress Report Publication List (RENEWAL)

    Who must complete the "Progress Report Publication List" attachment:

    A "Progress Report Publication List" is required only if the type of application is renewal.

    Descriptions of different types of applications are listed here: NIH Types of Applications.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    In the rare instance that you are submitting a renewal application, list the titles and complete references to all appropriate publications, manuscripts accepted for publication, patents, and other printed materials that have resulted from the project since it was last reviewed competitively.

    Interim research products are considered allowable citations for applications submitted for due dates on or after May 25, 2017Beginning with application due dates on or after May 25, 2017, you are allowed to cite interim research products. Note: interim research products have specific rules and citation requirements. See related Frequently Asked Questions on citing interim research products and claiming them as products of your NIH award.

    Provide the NIH Manuscript Submission reference number (e.g., NIHMS97531) or the PubMed Central (PMC) reference number (e.g., PMCID234567) for the following types of articles:

    If the PMCID is not yet available because the Journal submits articles directly to PMC on behalf of their authors, indicate "PMC Journal - In Process." NIH maintains a list of such journals.

    Citations that are not covered by the NIH Public Access Policy, but are publicly available in a free, online format may include URLs or PMCID numbers along with the full reference. Note that copies of these publications are not accepted as appendix material.

    8. Training in the Responsible Conduct of Research

    Who must complete the "Training in the Responsible Conduct of Research" attachment:

    The "Training in the Responsible Conduct of Research" attachment is required.

    Format:

    Follow the page limits for Training in the Responsible Conduct of Research in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    The plan must address the five required instructional components outlined in the NIH Policy on Instruction in the Responsible Conduct of Research (RCR), as more fully described in the Supplemental Instructions, Part III, Section 1.16: Policy on Instruction in the Responsible Conduct of Research:

    1. Format: Describe the required format of instruction (i.e., face-to-face lectures, coursework, and/or real-time discussion groups). A plan with only on-line instruction is not acceptable.
    2. Subject Matter: Describe the breadth of subject matter (e.g., conflict of interest, authorship, data management, human subjects and animal use, laboratory safety, research misconduct, and research ethics).
    3. Faculty Participation: Describe the role of the mentor(s) and other faculty involvement in the instruction.
    4. Duration of Instruction: Describe the total number of contact hours of instruction, taking into consideration the duration of the program.
    5. Frequency of Instruction: Instruction must occur during each career stage and at least once every four years. Document any prior instruction during the applicant's current career stage, including the inclusive dates instruction was last completed.

    Senior fellows may fulfill the requirement for instruction in RCR by participating as lecturers and discussion leaders.

    For more information:

    See the NIH Guide Notices on the Availability of Resources for Instruction in the Responsible Conduct of Research and on the Requirement for Instruction in the Responsible Conduct of Research.

    See the Supplemental Instructions, Part III, Section 1.16: Policy on Instruction in the Responsible Conduct of Research for information on the NIH Policy on Training in RCR.

    Sponsor(s), Collaborator(s), and Consultant(s) Section

    9. Sponsor and Co-Sponsor Statements

    Who must complete the "Sponsor and Co-Sponsor Statement" attachment:

    The "Sponsor and Co-Sponsor Statement" attachment is required. Both the Sponsor and all Co-Sponsors must provide statements as described below.

    Format:

    Follow the page limits for Sponsor and Co-Sponsor Statements in the NIH Table of Page Limits unless otherwise specified otherwise in the FOA.

    The Sponsor and Co-Sponsor Statements must be appended together and uploaded as a single PDF file. See NIH's Format Attachments page.

    Content:

    Complete these items as comprehensively as possible so that a meaningful evaluation of the training environment can be made by the reviewers.

    Create a heading at the top of the first page titled "Sponsor and Co-Sponsor Statements." Organize each statement in the specified order and use the instructions below, unless otherwise specified in the FOA. Start each section with the appropriate section heading - Research Support Available; Sponsor's/Co-Sponsor's Previous Fellows/Trainees; Training Plan, Environment, Research Facilities; Number of Fellows/Trainees to be Supervised During the Fellowship; and Applicant's Qualifications and Potential for a Research Career.

    Each sponsor and co-sponsor statement must address all of the following sections (A-E).

    A. Research Support Available

    In a table, list all current and pending research and research training support specifically available to the applicant for this particular training experience. Include funding source, complete identifying number, title of the research or training program, name of the PD/PI, start and end dates, and the amount of the award. If the sponsor's research support will end prior to the end of the proposed training period, the sponsor should describe a contingency plan for how the fellow's research will be supported.

    The role of the sponsor/co-sponsor in the Research Training Plan should be described. If one or more co-sponsors is proposed, this plan should describe the role of each sponsor and how they will communicate and coordinate their efforts to mentor the applicant effectively.

    B. Sponsor's/Co-Sponsor's Previous Fellows/Trainees

    State the total number of predoctoral and postdoctoral individuals previously sponsored. Select up to five that are representative, and for those five, provide information on their time spent in the lab, their present employing organizations, and their present position titles or occupations.

    C. Training Plan, Environment, Research Facilities

    The applicant's Research Training Plan should be individualized for the applicant, keeping in mind the candidate's strengths and any gaps in needed skills. The Research Training Plan should be designed to enhance both research and clinical training (if applicable).

    Describe the Research Training Plan that you have developed specifically for the fellowship applicant. Be sure to include the following points:

    • Include items such as classes, seminars, opportunities for interaction with other groups and scientists, and any professional skills development opportunities.
    • Describe the research environment and available research facilities and equipment.
    • Indicate the relationship of the proposed research training to the applicant's career goals.
    • Describe the skills and techniques that the applicant will learn. Relate these to the applicant's career goals.

    The information contained in the "Training Plan, Environment, Research Facilities" section of the Sponsor's and Co-sponsors' Statements should be coordinated with information provided under the Description of Institutional Environment and Commitment to Training attachment below.

    F30 Applications: The Research Training Plan should provide opportunities to integrate clinical experiences during the research training component; a plan for a smooth transition to the clinical training component; and should have the potential to facilitate the applicant's transition to a residency or other program appropriate for his/her career goals. Sponsors and co-sponsors should discuss these clinical aspects of the applicant's training as well.

    F31, F32, F33 Applications: The Research Training Plan should facilitate the applicant's transition to the next stage of his/her career. Sponsors and co-sponsors should discuss this aspect of the Research Training Plan as well.

    D. Number of Fellows/Trainees to be Supervised During the Fellowship

    Indicate how many pre- and/or post- doctoral fellows/trainees the Sponsor/Co-sponsor is expected to supervise during the award period. Co-sponsor statements must also include this information.

    E. Applicant's Qualifications and Potential for a Research Career

    Describe how the fellowship applicant is suited for this research training opportunity based on his/her academic record and research experience level. Include information about how the Research Training Plan, and your own expertise as the sponsor or co-sponsor, will assist in producing an independent researcher.

    10. Letters of Support from Collaborators, Contributors, and Consultants

    Note that Letters of Support are not the same as Reference Letters, which are required for some fellowship award applications. For more information about Reference Letters see the NIH Reference Letters page.

    Format:

    Follow the page limits for Letters of Support from Collaborators, Contributors, and Consultants in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Letters of support must be appended together and uploaded as a single PDF file. See NIH's Format Attachments page.

    Content:

    If any collaborators, consultants, or advisors are expected to make substantive contributions to the fellow's planned project and research training, attach letters of support from those individuals here, describing their anticipated role and contributions.

    Institutional Environment and Commitment to Training Section

    11. Description of Institutional Environment and Commitment to Training

    Who must complete the "Description of Institutional Environment and Commitment to Training" attachment:

    The "Description of Institutional Environment and Commitment to Training" attachment is required, and includes "Educational Information" for F30 and F31 applications.

    Format:

    Follow the page limits for the Description of Institutional Environment and Commitment to Training in the NIH Table of Page Limits unless otherwise specified in the FOA.

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Document a strong, well-established research program related to the candidate's area of interest. Describe opportunities for intellectual interactions with other investigators, including courses offered, journal clubs, seminars, and presentations. Indicate the facilities and other resources that will be made available for both career enhancement and the research proposed in this application. Refer to the resources description in G.220 - R&R Other Project Information Form, Facilities and Other Resources, and information provided in the Sponsor and Co-sponsor Statements attachment.

    F30 and F31 applications: Educational Information

    Describe the institution's dual-degree (F30) or graduate (F31) program in which the applicant is enrolled. This description should include the structure of the program, the required milestones and their usual timing, the number of courses, any teaching commitments or qualifying exams, and the average time to degree over the past 10 years. Describe the progress/status of the applicant in relation to the program's timeline, and the frequency and method by which the program formally monitors and evaluates a student's progress.

    For F30 applications specifically, describe any clinical tutorials during the graduate research years and any activities to ease transition from the graduate to the clinical years of the dual-degree program. Describe any research-associated activities during the clinical years of the dual-degree program.

    Include the name of the individual providing this information at the end of the description. This information is typically provided by the director of the graduate program or the department chair.

    Other Research Training Plan Section

    Human Subjects

    Are Human Subjects Involved? Yes/No

    This field is pre-populated from the G.220 - R&R Other Project Information Form.

    If you have answered "No": If the answer is "No" to the question "Are Human Subjects Involved?" but your proposed research involves human specimens and/or data from subjects, you must provide a justification in the Protection of Human Subjects attachment below for your claim that no human subjects are involved. You do not need to complete the other questions in the Human Subjects section.

    If you have answered "Yes": Consult with your Sponsor and Administrative Officials (AO) at the Sponsoring Institution as you complete this section, and also refer to .

    Note that human subjects requirements may apply even if you are obtaining specimens/data from collaborators or if you are subcontracting the human research to another organization.

    Refer to the NIH's Research Involving Human Subjects website for more information.

    12. Human Subjects Involvement Indefinite?

    An answer to this question is required if you answered "Yes" to the question "Are Human Subjects Involved?" on the G.220 - R&R Other Project Information Form.

    Check "Yes" if plans for the involvement of human subjects have not been finalized at the time of application, thus making an IRB review and approval unfeasible at this stage. This situation is also referred to "delayed onset human subjects research." If an award is made, you may not participate in human subjects research until both a Protection of Human Subjects section and the certification of the date of IRB approval has been submitted to and approved by the awarding component.

    Check "No" if, at the time of application, the above conditions do not apply to you.

    13. Clinical Trial

    An answer to this question is required if you answered "Yes" to the question "Are Human Subjects Involved?" on the G.220 - R&R Other Project Information Form.

    Check "Yes" or "No" to indicate whether the project includes a clinical trial.

    Refer to the NIH Glossary for the definition of a clinical trial.

    14. Agency-Defined Phase III Clinical Trial?

    An answer to this question is required if you answered "Yes" to the "Clinical Trial?" question above.

    Check "Yes" or "No" to indicate whether the project is or includes an NIH-defined Phase III clinical trial.

    Refer to the NIH Glossary for the definition of a Phase III clinical trial.

    15. Protection of Human Subjects

    Who must complete the "Protection of Human Subjects" attachment:

    Include a "Protection of Human Subjects" attachment if you answered "Yes" to the question "Are human subjects involved?" on the G.220 - R&R Other Project Information Form.

    If you answered "No" to the "Are human subjects involved?" question but your proposed research involves human specimens and/or data from subjects, you must provide a justification in this section for your claim that no human subjects are involved.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Do not use the "Protection of Human Subjects" section to circumvent the page limits of the Research Strategy.

    Content:

    Refer to for instructions on this attachment. Additionally, be sure to follow any specific instructions in your FOA.

    For more information:

    Refer to the NIH's Research Involving Human Subjects website.

    16. Data Safety Monitoring Plan

    Who must complete the "Data Safety Monitoring Plan" attachment:

    Include a "Data Safety Monitoring Plan" attachment if you answered "Yes" to question Clinical Trial? above.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Refer to Supplemental Instructions, Part II, Section 4.1.5: Data and Safety Monitoring Plan for instructions on this attachment.

    17. Inclusion of Women and Minorities

    Who must complete the "Inclusion of Women and Minorities" attachment:

    Include an "Inclusion of Women and Minorities" attachment if you answered "Yes" to the question "Are human subjects involved" on the G.220 - R&R Other Project Information Form and the research does not fall under Exemption 4.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Refer to Supplemental Instructions, Part II, Section 4.2: Inclusion of Women and Minorities for instructions on this attachment.

    Additionally, refer to Section G.500 - PHS Inclusion Enrollment Report as well as the for more information on submitting PHS Inclusion Enrollment Report as part of your application.

    18. Inclusion of Children

    Who must complete the "Inclusion of Children" attachment:

    Include an "Inclusion of Children" attachment if you answered "Yes" to the question "Are human subjects involved?" on the G.220 - R&R Other Project Information Form and the research does not fall under Exemption 4.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Refer to .

    Vertebrate Animals

    Are Vertebrate Animals Used?

    This field is pre-populated from the G.220 - R&R Other Project Information Form.

    If you have answered "No" for activities involving vertebrate animals and activities involving vertebrate animals are not planned at any time during the proposed project at any performance site: Skip Questions 19 and 20 below.

    If you have answered "Yes" for activities involving vertebrate animals: Answer Questions 19 and 20 below in consultation with both your Sponsor and AO.

    19. Vertebrate Animals Use Indefinite?

    An answer is required if you answered "Yes" to "Are Vertebrate Animals Used?" above.

    Check "Yes" if plans for the involvement of vertebrate animals have not been finalized at the time of application, thus making an IACUC review and approval not yet feasible. If an award is made, vertebrate animals may not be used until a "Vertebrate Animals" attachment and certification of IACUC approval has been submitted and approved by the awarding component.

    20. Are vertebrate animals euthanized?

    An answer is required if you answered "Yes" to "Are Vertebrate Animals Used?" above.

    Check "Yes" or "No" to indicate whether animals in the project are euthanized.

    If "Yes" to euthanasia, is method consistent with AVMA guidelines?

    An answer is required if you answered "Yes" to "Are Vertebrate Animals Euthanized?"

    Check "Yes" or "No" to indicate whether the method of euthanasia is consistent with the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals.

    For more information: See AVMA Guidelines for the Euthanasia of Animals.

    If "No" to AVMA guidelines, describe method and provide scientific justification:

    If you answered "No" to "Is method consistent with AVMA guidelines?," you must describe (in 1000 characters or fewer) the method of euthanasia and provide a scientific justification for its use.

    If you answered "Yes" to "Is method consistent with AVMA guidelines?" skip this question and scientific justification.

    21. Vertebrate Animals

    Who must complete the "Vertebrate Animals" attachment:

    Include a "Vertebrate Animals" attachment if you answered "Yes" to the question "Are Vertebrate Animals Used?" on the G.220 - R&R Other Project Information Form.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Do not use the Vertebrate Animals attachment to circumvent the page limits of the Research Strategy.

    Content:

    If vertebrate animals are involved in the project, address each of the following criteria:

    1. Description of Procedures: Provide a concise description of the proposed procedures to be used that involve vertebrate animals in the work outlined in the "Research Strategy" attachment. Identify the species, strains, ages, sex, and total numbers of animals by species, to be used in the proposed work. If dogs or cats are proposed provide the source of the animals.
    2. Justifications: Provide justification that the species are appropriate for the proposed research. Explain why the research goals cannot be accomplished using an alternative model (e.g., computational, human, invertebrate, in vitro).
    3. Minimization of Pain and Distress: Describe the interventions, including analgesia, anesthesia, sedation, palliative care, and humane endpoints, that will be used to minimize discomfort, distress, pain, and injury.

    Provide a concise, complete description of the animals and proposed procedures. In addition to the three points above, you should also:

    • Identify all project/performance or collaborating site(s) and describe activities of proposed research with vertebrate animals in those sites.
    • Explain when and how animals are expected to be used if plans for the use of animals have not been finalized.

    See the following pages for more information:

    22. Select Agent Research

    Who must complete the "Select Agent Research" attachment:

    Include a "Select Agent Research" attachment if your proposed activities involve the use of select agents at any time during the proposed project period, either at the applicant organization or at any performance site.

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    For more information:

    Select agents are hazardous biological agents and toxins that have been identified by HHS or the U.S. Department of Agriculture (USDA) as having the potential to pose a severe threat to public health and safety, to animal and plant health, or to animal and plant products. The Centers for Disease Control and Prevention (CDC) and the Animal APHIS Select Agent Programs jointly maintain a list of these agents. See the Federal Select Agent Program website.

    See also the .

    Content:

    Excluded select agents: If the activities proposed in the application involve only the use of a strain(s) of select agents which has been excluded from the list of select agents and toxins as per 42 CFR 73.3, the select agent requirements do not apply. Use this "Select Agent Research" attachment to identify the strain(s) of the select agent that will be used and note that it has been excluded from this list. The CDC maintains a list of exclusions, which is available on the Select Agents and Toxins Exclusions website.

    Applying for a select agent to be excluded: If the strain(s) is not currently excluded from the list of select agents and toxins but you have applied or intend to apply to HHS for an exclusion from the list, use this section to indicate the status of your request or your intent to apply for an exclusion and provide a brief justification for the exclusion.

    All applicants proposing to use select agents: Address the following three points for each site at which select agent research will take place. Although no specific page limitation applies to this section, be succinct.

    1. Identify the select agent(s) to be used in the proposed research.

    2. Provide the registration status of all entities* where select agent(s) will be used.

    • If the performance site(s) is a foreign institution, provide the name(s) of the country or countries where select agent research will be performed.
    • *An "entity" is defined in 42 CFR 73.1 as "any government agency (federal, state, or local), academic institution, corporation, company, partnership, society, association, firm, sole proprietorship, or other legal entity."

    3. Provide a description of all facilities where the select agent(s) will be used.

    • Describe the procedures that will be used to monitor possession, use, and transfer of select agent(s).
    • Describe plans for appropriate biosafety, biocontainment, and security of the select agent(s).
    • Describe the biocontainment resources available at all performance sites.

    23. Resource Sharing Plan

    Format:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    Content:

    Data Sharing Plan: Investigators seeking $500,000 or more in direct costs (exclusive of consortium F&A) in any budget period are expected to include a brief 1-paragraph description of how final research data will be shared, or explain why data-sharing is not possible (for example human subject concerns, the Small Business Innovation Development Act provisions, etc.). Specific FOAs may require that all applications include this information regardless of the dollar level. Applicants are encouraged to read the FOA carefully and discuss their data-sharing plan with their program contact at the time they negotiate an agreement with the Institute/Center (IC) staff to accept assignment of their application. For more information, see the NIH Data Sharing Policy or the NIH Guide Notice on Sharing Research Data.

    Sharing Model Organisms: Regardless of the amount requested, all applications where the development of model organisms is anticipated are expected to include a description of a specific plan for sharing and distributing unique model organisms or state why such sharing is restricted or not possible. For more information, see and the NIH Guide Notice on Sharing Model Organisms for Biomedical Research.

    Genomic Data Sharing (GDS): Applicants seeking funding for research that generates large-scale human or non-human genomic data are expected to provide a plan for sharing of these data. Examples of large-scale genomic data include genome-wide association studies (GWAS), single nucleotide polymorphisms (SNP) arrays, and genome sequence, transcriptomic, epigenomic, and gene expression data. Supplemental Information to the NIH GDS provides examples of genomic research projects that are subject to the Policy. For more information, see the NIH GDS Policy, the NIH Guide Notice on Genomic Data Sharing Policy, and the GDS website.

    Note on GDS: For proposed studies generating human genomic data under the scope of the GDS Policy, an Institutional Certification may be submitted at the time of application submission, but it is not required at that time. The Institutional Certification, however, will be requested as Just-in-Time (JIT) information prior to award. The Institutional Certification, or in some cases, a Provisional Institutional Certification, must be submitted and accepted before the award can be issued.

    For more information:

    NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value and further the advancement of the research. When resources have been developed with NIH funds and the associated research findings published or provided to NIH, it is important that they be made readily available for research purposes to qualified individuals within the scientific community. See Supplemental Instructions, Part III, Section 1.5: Sharing Research Resources.

    24. Authentication of Key Biological and/or Chemical Resources

    Do not submit an "Authentication of Key Biological and/or Chemical Resources" attachment unless it is specifically requested in the FOA.

    Additional Information Section

    25. Human Embryonic Stem Cells

    Use the following instructions to complete the fields in this section.

    For additional guidance, see the NIH Guide Notice on the Change in Requirements for NIH Applications Involving Human Embryonic Stem Cells.

    Does the proposed project involve human embryonic stem cells (hESC)?

    An answer to this question is required.

    If the proposed project involves hESC, check "Yes" and complete the rest of the fields in the Human Embryonic Stem Cells section.

    If the proposed project does not involve hESC, check "No" and skip the rest of fields in the Human Embryonic Stem Cells section.

    Specific stem cell line cannot be referenced at this time. One from the registry will be used.

    If you will use hESC but a specific line from the NIH hESC Registry cannot be chosen at the time of application submission, check this box. Additionally, provide a strong justification (in the Research Strategy) for why an appropriate cell line cannot be chosen from the registry at this time.

    If you cannot specify which cell lines will be used at the time of application submission, specific cell line information will be required as Just-in-Time information prior to award.

    Cell Line(s):

    List the 4-digit registration number of the specific cell line(s) from the NIH hESC Registry (e.g. 0123). Up to 200 lines can be added.

    26. Alternate Phone Number

    Enter an alternate phone number (e.g., cell phone) for the fellowship applicant. This should be a different number than the one provided in the PD/PI contact information in the G.200 - SF424 (R&R) Form.

    27. Degree Sought During Proposed Award

    Complete the following fields if you will be working toward a degree while receiving fellowship support.

    Degree:

    Select the type of degree you will be working toward during the proposed award. If the degree is not on the drop down menu, please select "OTH: Other."

    If "other," please indicate degree type:

    If you selected "OTH: Other" for the "Degree," indicate the type of degree you will be working toward during the proposed award.

    Expected Completion Date (month/year):

    Enter the expected completion date of the degree sought during the proposed award.

    28. Field of Training for Current Proposal

    An answer to this field required.

    Select a single "Field of Training" code that best describes the proposed area of research training. This information is used for reporting purposes only and is not used for study section assignments.

    29. Current or Prior Kirschstein-NRSA Support?

    Current or Prior Kirschstein-NRSA Support? Yes/No

    An answer to this question is required. Check the appropriate box to indicate whether you currently have or have had prior Kirschstein-NRSA support.

    If "Yes," identify current and prior Kirschstein-NRSA support below:

    Select the appropriate "Level" and "Type" of Kirschstein-NRSA support. "Level" indicates either predoctoral or postdoctoral level (not the level of experience). "Type" indicates either individual fellowship or institutional research training grant.

    If known, enter the start and end dates (month, day, and year) of the support and the grant number (e.g., T32 GM123456 or F31 HL345678) of the current and/or prior support.

    You may enter up to four separate listings for current and/or prior support.

    Note on Kirschstein-NRSA time limits: An individual cannot receive more than five years of cumulative predoctoral Kirschstein-NRSA support and three years cumulative postdoctoral Kirschstein-NRSA support (the total of institutional grants and individual fellowships) without a waiver from the awarding component. The awarding components have different policies on waiving the statutory limits on support. Therefore, the fellowship applicant must request a waiver from the probable awarding IC before requesting a period of support that would exceed these limits. Refer to the Table of IC-specific Information, Requirements, and Staff Contacts in your FOA. The fellow's sponsor and AOR must endorse the request. The request must include justification and specify the amount of additional support for which approval is sought. Individuals seeking additional support beyond the third year of postdoctoral support are strongly advised to consult with their awarding IC Program Officer before submitting a waiver request. It is important to read carefully the applicable FOA that may have an overall approval to exceed these limits (e.g., the F30 programs allow for up to six years of predoctoral support).

    If you receive additional NRSA support while this application is pending, you must promptly report such information to the awarding component to which this application has been assigned.

    30. Applications for Concurrent Support?

    Applications for Concurrent Support? Yes/No

    An answer to this question is required. Check the appropriate box to indicate whether the fellowship applicant has applied or will be applying for other support that would run concurrently with the period covered by this application.

    If yes, please describe in an attached file:

    Attach this information as a PDF file. See NIH's Format Attachments page.

    If you answered "Yes" to the "Applications for Concurrent Support?" question, you must provide a description of the concurrent support. Include the type, dates, source(s), and amount in the attachment.

    If you receive any support from these other applications while this application is pending, you must promptly report such information to the awarding component to which this application has been assigned.

    31. Citizenship

    Information on Citizenship Requirements for Fellowship Applicants:

    Individual NRSA Fellowship Requirements: To be eligible for a Kirschstein-NRSA individual fellowship (F30, F31, F32, F33), the fellowship applicant must be a citizen or non-citizen national of the United States or of its possessions or territories, or must have been lawfully admitted to the United States for permanent residence by the time the award is issued. Individuals on temporary student visas are not eligible for NRSA support unless otherwise specified in the FOA.

    Non-NRSA Requirements: If you are applying for a non-NRSA fellowship program supported by the NIH for which citizenship or permanent residency is not required (e.g., Fogarty International Center programs, F99/K00), you must have a valid visa in your possession that allows you to remain in the United States (or in a foreign research training setting, if applicable) long enough to be productive on the proposed fellowship project. It is the responsibility of the sponsoring institution to determine and document in the application that the individual fellowship applicant's visa will allow him or her to remain in the proposed research training setting for the period of time necessary to complete the proposed fellowship. Information may be requested by the NIH or another PHS Agency prior to issuance of an award.

    All Fellowship Applicants:

    Check the applicable boxes for the following questions:

    U.S. Citizen: U.S. Citizen or Non-Citizen National? Yes/No

    Check "Yes" if the candidate is a U.S. Citizen or Non-Citizen national; otherwise check "No."

    If you answered "Yes," skip the rest of "Question 31. Citizenship" and you can continue with "Question 32. Change of Sponsoring Institution."

    If you answered "No," please continue to fill out the rest of "Question 31. Citizenship" following the instructions below.

    Non-Citizen nationals are people who, although not citizens of the United States, owe permanent allegiance to the United States. They generally are people born in outlying possessions of the United States (e.g., American Samoa and Swains Island).

    If "No" to U.S. Citizen or Non-Citizen National, please select the most appropriate response from the options provided:
    Non-U.S. Citizen With a Permanent U.S. Resident Visa:

    Check this box if the fellowship applicant has been lawfully admitted for permanent residence (i.e., is in the possession of a current and valid Permanent Resident Card or other legal verification of such status).

    A notarized statement will be required before an award is issued. The statement must show that a licensed notary has seen the fellowship applicant's valid Permanent Resident Card (USCIS Form I-551) or other valid verification from the U.S. Immigration and Naturalization Service of legal admission to the U.S.

    Non-U.S. Citizen With a Temporary U.S. Visa:

    Check this box if the fellowship applicant currently holds a temporary U.S. visa.

    If you are a non-U.S. citizen with a temporary visa who has applied for permanent resident status and expect to hold a permanent resident visa by the earliest possible start date of the award, please also check here:

    If the fellowship applicant has applied for permanent residence and expects to hold a permanent resident visa by the earliest possible start date of the award, please check this box to indicate that permanent residence status is pending. A notarized statement will be required as a part of the pre-award process.

    32. Change of Sponsoring Institution

    Check this box if you are submitting your application with a change of sponsoring institution. If the box is checked, you must also provide the name of the former sponsoring institution.

    Budget Section

    1. Tuition and Fees

    Who must complete the "Tuition and Fees" section:

    All fellowship applicants must complete this "Tuition and Fees" section.

    Content:

    Indicate whether funds are being requested for tuition and fees by checking the appropriate box ("None Requested" or "Funds Requested").

    Predoctoral Fellowship Applicants: List, by year, the estimated costs of tuition and fees.

    Postdoctoral and Senior Fellowship Applicants: List, by year, the costs associated with specific courses that both support the research training experience and that are identified and described in the "Activities Planned Under this Award" section of the Applicant's Background and Goals for Fellowship Training attachment.

    For more information:

    In accordance with NIH Guide Notice on Ruth L. Kirschstein National Research Service Award Policy, funds to offset the costs of health insurance are included in the standard Institutional Allowance, and are not to be requested as part of Tuition and Fees.

    Refer to the NIH Research Training and Career Development website for helpful resources and FAQs about tuition and fees.

    2. Present Institutional Base Salary

    Who must complete the "Institutional Base Salary" section:

    Only senior fellowship applicants should complete the "Institutional Base Salary" section.

    Amount:

    Provide your present base salary. The value must be in U.S. dollars.

    Academic Period:

    Indicate the period of time on which the salary is determined (e.g., academic year of 9 months, full-time 12 months, etc.).

    Number of Months:

    Indicate the number of months per year you receive your base salary. The number may not be more than 12, but may include a decimal to indicate partial months (e.g., 9.5).

    3. Stipends/Salary During First Year of Proposed Fellowship

    Who must complete the "Stipends/Salary During First Year of Proposed Fellowship" section:

    Only senior fellowship applicants should complete the "Stipends/Salary During First Year of Proposed Fellowship" section.

    a. Federal Stipend Requested: Amount and Number of Months

    Enter the amount of the stipend being requested for the initial period of support (i.e., the first year of proposed fellowship) and the number of months requested.

    b. Supplementation from other sources: Amount, Number of Months, Type, and Source

    Enter the anticipated amount and the number of months (during the first year of the proposed fellowship) for any stipend/salary supplementation. Also enter the type of supplementation expected (e.g., sabbatical leave, salary, etc.) and the source of such funding.

    Appendix

    Appendix

    A new appendix policy has taken effect, which redefines the allowable appendix materials.Refer to the FOA to determine whether an appendix is allowed in your application.

    Format:

    A maximum of 10 PDF attachments is allowed in the Appendix. If more than 10 Appendix attachments are needed, combine the remaining information into attachment #10. Note that this is the total number of Appendix items, not the total number of publications.

    For materials that cannot be submitted electronically or materials that cannot be converted to PDF (e.g., medical devices, prototypes, DVDs, CDs), applicants should contact the Scientific Review Officer following notification of assignment of the application to a study section. Applicants are encouraged to be as concise as possible and submit only information essential for the review of the application.

    Do not use the Appendix to circumvent the page limits of the Research Strategy or any other section of the application for which a page limit applies. For additional information regarding appendix material and page limits, refer to the NIH Guide Notice on Compliance with NIH Application Format and Content Instructions.

    Use file names for attachments that are descriptive of the content.

    A summary sheet listing all of the items included in the Appendix is encouraged but not required. When including a summary sheet, it should be included in the first Appendix attachment.

    Content:

    The only allowable appendix materials are:

    For applications proposing clinical trials (unless the FOA provides other instructions for these materials):

    • Clinical trial protocols
    • Investigator's brochure from Investigational New Drug (IND), as appropriate

    For all applications:

    • Blank informed consent/assent forms
    • Blank surveys, questionnaires, data collection instruments
    • FOA-specified items
      • If Appendix materials are required in the FOA, review criteria for that FOA will address those materials, and applications submitted without those Appendix materials will be considered incomplete and will not be reviewed.

    Note: Applications that do not follow the appendix requirements will not be reviewed. Applications submitted for due dates on or after January 25, 2017 will be withdrawn and not reviewed if they are submitted with appendix materials that are not specifically listed in this section.

    For more information:

     

    Leave a Comment

    (0 Comments)

    Your email address will not be published. Required fields are marked *